This inventor holds 1 USPTO granted patent. Top assignees: National Institute of Health and Medical Research, Schering Corporation, Schering-Plough Corporation. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2000
Title: The Innovations of Leopoldo Flores-Romo
Introduction
Leopoldo Flores-Romo is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biomedical research, particularly in the area of immunology. His work has led to advancements in therapeutic methods for treating various physiological conditions.
Latest Patents
Leopoldo holds a patent titled "Uses of mammalian CTLA-8 and related reagents." This patent focuses on compositions and methods for using CTLA-8 to treat abnormal physiological conditions in individuals. The methods involve administering a therapeutically effective amount of CTLA-8, either alone or in combination with other therapeutic reagents, or utilizing a CTLA-8 antagonist. He has 1 patent to his name.
Career Highlights
Throughout his career, Leopoldo has worked with prominent companies in the pharmaceutical industry, including Schering-Plough Corporation and Schering Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in therapeutic treatments.
Collaborations
Leopoldo has collaborated with esteemed colleagues in his field, including Pierre Golstein and Jacques F. Banchereau. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Leopoldo Flores-Romo's contributions to biomedical research and his innovative patent on CTLA-8 highlight his significant role in advancing therapeutic methods. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile